Treating a wound requires materials – dressings, cleansers and so on – but also nursing time and hospitalization. Studies show that the total cost of wound care treatment can be broken down into 15–20% for dressing materials, 30–35% for nursing time and >50% for hospital costs (1).

This makes it critical to look at total cost of treatment and the patient experience instead of unit cost for a given product when making purchasing decisions.

In wound care, Coloplast creates value by enabling healthcare professionals to manage various wound etiologies and use fewer resources, improving quality of life for patients while containing overall costs.

With longer wear time, fewer dressings are required for each wound. This means less nursing time is needed for changing dressings .The graphs below compares Biatain Silicone with two competing dressings. Because Biatain Silicone offers superior handling of exudate, the dressing can be worn for longer, reducing the number of dressing changes required and thus reducing overall cost (3,4)

The cost of hard-to-heal/infectious wounds is affected by prolonged and intensified treatment, as well as prolonged hospitalization and specialized treatment, possibly including surgical interventions (1).

Reduced wound management time enables you to save significant resources, including nursing time, number of dressings, antibiotics, diagnostics and transfer costs, while also improving quality of life for your patients.

Biatain® Ag- for wounds at-risk of infection

Learn more about Biatain Ag